Key Takeaway
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
Published June 30, 2026 · Category: News
Overview
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
Details
(Image credit: Svitlana Pietukhova/iStockphoto)
Source
Originally published at www.npr.org.
Related Articles
Frequently Asked Questions
What is "FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports" about?+
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
Who reported this story?+
This story was reported by NPR News.